Lipopolysaccharide results in a marked decrease in hepatocyte nuclear factor 4αin rat liver

Hepatology

Volumn 34, Issue 5, 2001, Pages 979-989

  Wang, Bin ^a   Cai, Shi Rong ^a   Gao, Cuihua ^a   Sladek, Frances M ^a   Ponder, Katherine Parker ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; HEPATOCYTE NUCLEAR FACTOR 4; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEASOME INHIBITOR; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; LIVER FAILURE; LIVER FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; TISSUE SPECIFICITY;

EID: 0034768779     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.28885     Document Type: Article

References (59)

1. The molecular pathogenesis of endotoxic shock and organ failure
2. The inflammatory basis of trauma/shock-associated multiple organ failure
3. Sepsis-induced depression of rat glucose-6-phosphatase gene expression and activity
4. Glycolytic enzyme activities in normal and diabetic dog livers during endotoxic shock
5. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models
6. Evidence for posttranscriptional regulation of C/EBPalpha and C/EBPbeta isoform expression during the lipopolysaccharide-mediated acute-phase response
7. Effects of age on the posttranscriptional regulation of CCAAT/enhancer binding protein alpha and CCAAT/enhancer binding protein beta isoform synthesis in control and LPS-treated livers
8. Endotoxin dowmregulates rat hepatic NTCP gene expression via decreased activity of critical transcription factors
9. Liver-enriched transcription factors and hepatocyte differentiation
10. Analysis of protein dimerization and ligand binding of orphan receptor HNF4alpha
11. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha
12. Cloning and sequencing of cDNAs encoding the human hepatocyte nuclear factor 4 indicate the presence of two isoforms in human liver
13. Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes
14. Organization and partial sequence of the hepatocyte nuclear factor-4 alpha/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY
15. Identification of two splice isoforms of mRNA for mouse hepatocyte nuclear factor 4 (HNF-4)
16. Isolation and characterization of a third isoform of human hepatocyte nuclear factor 4
17. An alternative splice variant of the tissue specific transcription factor HNF4alpha predominates in undifferentiated murine cell types
18. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily
19. Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos
20. Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha
21. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis
22. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)
23. Genotype/phenotype relationships in HNF-4alpha/MODY1: Haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels
24. Genetic analysis of a transcriptional activation pathway by using hepatoma cell variants
25. Hepatocyte nuclear factor-4 prevents silencing of hepatocyte nuclear factor-1 expression in hepatoma X fibroblast cell hybrids
26. Hepatocyte nuclear factor 4 expression overcomes repression of the hepatic phenotype in dedifferentiated hepatoma cells
27. Lipopolysaccharide potentiates the effect of hepatocyte growth factor on hepatocyte replication in rats by augmenting AP-1 activity
28. Chicken ovalbumin upstream promoter transcription factors act as auxiliary cofactors for hepatocyte nuclear factor 4 and enhance hepatic gene expression
29. Identification of an extended half-site motif required for the function of peroxisome proliferator-activated receptor alpha
30. Liver-directed gene therapy: Quantitative evaluation of promoter elements by using in vivo retroviral transduction
31. Analysis of pre-rRNAs in heat-shocked HeLa cells allows identification of the upstream termination site of human polymerase I transcription
32. DNA binding and transcription activation specificity of hepatocyte nuclear factor 4
33. Multiple parameters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR and RXR through common response elements
34. Acetylation regulates transcription factor activity at multiple levels
35. Analysis of the rat hepatocyte nuclear factor (HNF) 1 gene promoter: Synergistic activation by HNF4 and HNF1 proteins
36. Positive regulation of the vHNF1 promoter by the orphan receptors COUP-TF1/Ear3 and COUP-TFII/Arp1
37. Tissue-specific expression of the gene encoding hepatocyte nuclear factor 1 may involve hepatocyte nuclear factor 4
38. A transcriptional hierarchy involved in mammalian cell-type specification
39. Mechanism for biphasic rel A. NF-kappaB1 nuclear translocation in tumor necrosis factor alpha-stimulated hepatocytes
40. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation
41. The acute phase response is associated with retinoid X receptor repression in rodent liver
42. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes
43. 1, 25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin
44. Proteasome-mediated degradation of the vitamin D receptor (VDR) and a putative role for SUG1 interaction with the AF-2 domain of VDR
45. Proteasome-dependent degradation of the human estrogen receptor
46. Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors
47. Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation
48. Ubiquitin-dependent protein degradation
49. PEST sequences and regulation by proteolysis
50. Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1
51. Primary structure, chromosomal mapping, expression and transcriptional activity of murine hepatocyte nuclear factor 4gamma
52. Hepatocyte nuclear factor-4gamma: Cdna sequence, gene organization, and mutation screening in early-onset autosomal-dominant type 2 diabetes
53. A common regulatory locus affects both HNF4/HNF1(α) pathway activation and sensitivity to LPS-mediated apoptosis in rat hepatoma cells
54. Phases of glucose dyshomeostasis in endotoxicosis
55. Lovastatin decreases mortality and improves liver functions in fulminant hepatic failure from 90% partial hepatectomy in rats
56. Blocking IL-1: Interleukin 1 receptor antagonist in vivo and in vitro
57. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
58. Sepsis-induced muscle proteolysis is prevented by a proteasome inhibitor in vivo
59. Proteasome participates in the pathogenesis of ischemic acute renal failure in rats